Buti M, Casado MA, Fosbrook L, Esteban R Financial impact of two different ways of evaluating early virological response to peginterferon alfa-2b plus ribavirin therapy in genotype 1 naïve patients with chronic hepatitis C Pharmacoeconomics. 2005;23:1043-55 MÁS INFORMACIÓN
